Materials and Methods
Publication stageIn Press Journal Pre-Proof
CRediT Author Contribution Statement
Masaki Ishida, Kenji Morimoto, Tadaaki Yamada: Study conception and design.
Masaki Ishida, Kenji Morimoto, Takayuki Takeda, Shinsuke Shiotsu, Koji Date, Taishi Harada, Nobuyo Tamiya, Yusuke Chihara, Yoshizumi Takemura, Takahiro Yamada, and Hibiki Kanda: Obtained the clinical data.
Masaki Ishida, Kenji Morimoto, Tadaaki Yamada, Masahiro Iwasaku, Shinsaku Tokuda, Young Hak Kim, and Koichi Takayama: Data Interpretation.
Masaki Ishida, Kenji Morimoto, Tadaaki Yamada, and Koichi Takayama: Manuscript preparation.
The final version of the manuscript was read and approved by all the authors.
Conflict of interest
Tadaaki Y received grants from Pfizer, Ono Pharmaceutical, Janssen Pharmaceutical, and Takeda Pharmaceutical, and personal fees from Eli Lilly. KT received grants from Chugai Pharmaceutical and Ono Pharmaceutical, and personal fees from AstraZeneca, Chugai Pharmaceutical, MSD, Eli Lilly, Boehringer Ingelheim, and Daiichi Sankyo. The other authors have no conflicts of interest to declare.
User licenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy